KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Amortizatization of Intangibles (2017 - 2022)

Historic Amortizatization of Intangibles for Twist Bioscience (TWST) over the last 6 years, with Q3 2022 value amounting to $1.2 million.

  • Twist Bioscience's Amortizatization of Intangibles rose 1343.0% to $1.2 million in Q3 2022 from the same period last year, while for Sep 2023 it was $14.6 million, marking a year-over-year increase of 223.24%. This contributed to the annual value of $5.9 million for FY2023, which is 5849.07% down from last year.
  • Latest data reveals that Twist Bioscience reported Amortizatization of Intangibles of $1.2 million as of Q3 2022, which was up 1343.0% from $13.9 million recorded in Q2 2022.
  • Twist Bioscience's 5-year Amortizatization of Intangibles high stood at $13.9 million for Q2 2022, and its period low was -$472000.0 during Q1 2022.
  • In the last 5 years, Twist Bioscience's Amortizatization of Intangibles had a median value of $78000.0 in 2018 and averaged $866157.9.
  • As far as peak fluctuations go, Twist Bioscience's Amortizatization of Intangibles crashed by 180000.0% in 2021, and later surged by 751229.95% in 2022.
  • Over the past 5 years, Twist Bioscience's Amortizatization of Intangibles (Quarter) stood at $78000.0 in 2018, then skyrocketed by 92.31% to $150000.0 in 2019, then tumbled by 181.33% to -$122000.0 in 2020, then tumbled by 160.66% to -$318000.0 in 2021, then soared by 469.18% to $1.2 million in 2022.
  • Its last three reported values are $1.2 million in Q3 2022, $13.9 million for Q2 2022, and -$472000.0 during Q1 2022.